Researchers at IRB Barcelona have demonstrated that the decrease in Dab1 protein expression caused by the infective action of prions also reduces the production of β-amyloid, a risk factor of Alzheimer’s disease.
Epilepsy, cancer, diabetes and depression are just some examples of the severe diseases associated with mutations in these proteins.
The biotech company Omnia Molecular shared by IRB Barcelona, opens its new facilities in the Barcelona Science Park.
Otorgado por la revista Actualidad Económica y el diario Expansión
Researchers study the evolution of life by examining the translation of the genetic codes of several organisms, in order to discover differences between bacteria and humans that allow the design of new antibiotics
The finding of researchers at the Barcelona Supercomputing Center (BSC) and the Institute for Research in Biomedicine (IRB Barcelona) has been possible thanks to the calculation capacity of the MareNostrum supercomputer.
The European Research Council has awarded Eduard Batlle a Starting Grant for outstanding young researchers
IRB Barcelona will allocate 4.9 million Euros to attract young talented scientists over four years
Researchers at IRB Barcelona report the first data on the functions of a new gene that is altered in diabetes, published in PLoS One.
Biologist Marco Milán, Drosophila researcher at IRB Barcelona, has been awarded the EMBO Young Investigator Programme, given by the European Molecular Biology Organization (EMBO) to promising young European scientists for their early career excellence. The programme has been identifying and supporting on an annual basis some of the brightest young researchers in Europe since 2000.